Amdocs Statistics
Total Valuation
Amdocs has a market cap or net worth of $6.91 billion. The enterprise value is $7.62 billion.
| Market Cap | 6.91B |
| Enterprise Value | 7.62B |
Important Dates
The next estimated earnings date is Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | Mar 31, 2026 |
Share Statistics
Amdocs has 107.57 million shares outstanding. The number of shares has decreased by -4.44% in one year.
| Current Share Class | 107.57M |
| Shares Outstanding | 107.57M |
| Shares Change (YoY) | -4.44% |
| Shares Change (QoQ) | -1.22% |
| Owned by Insiders (%) | 1.01% |
| Owned by Institutions (%) | 100.97% |
| Float | 105.32M |
Valuation Ratios
The trailing PE ratio is 12.44 and the forward PE ratio is 8.45. Amdocs's PEG ratio is 1.02.
| PE Ratio | 12.44 |
| Forward PE | 8.45 |
| PS Ratio | 1.51 |
| Forward PS | 1.45 |
| PB Ratio | 2.02 |
| P/TBV Ratio | 39.42 |
| P/FCF Ratio | 9.16 |
| P/OCF Ratio | 8.00 |
| PEG Ratio | 1.02 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.44, with an EV/FCF ratio of 10.09.
| EV / Earnings | 13.34 |
| EV / Sales | 1.66 |
| EV / EBITDA | 7.44 |
| EV / EBIT | 9.24 |
| EV / FCF | 10.09 |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.27.
| Current Ratio | 1.06 |
| Quick Ratio | 0.83 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 0.87 |
| Debt / FCF | 1.26 |
| Interest Coverage | 26.47 |
Financial Efficiency
Return on equity (ROE) is 16.48% and return on invested capital (ROIC) is 16.71%.
| Return on Equity (ROE) | 16.48% |
| Return on Assets (ROA) | 8.16% |
| Return on Invested Capital (ROIC) | 16.71% |
| Return on Capital Employed (ROCE) | 16.89% |
| Weighted Average Cost of Capital (WACC) | 6.35% |
| Revenue Per Employee | $169,780 |
| Profits Per Employee | $21,178 |
| Employee Count | 26,969 |
| Asset Turnover | 0.72 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Amdocs has paid $121.86 million in taxes.
| Income Tax | 121.86M |
| Effective Tax Rate | 17.50% |
Stock Price Statistics
The stock price has decreased by -25.28% in the last 52 weeks. The beta is 0.47, so Amdocs's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -25.28% |
| 50-Day Moving Average | 66.54 |
| 200-Day Moving Average | 78.35 |
| Relative Strength Index (RSI) | 41.94 |
| Average Volume (20 Days) | 913,355 |
Short Selling Information
The latest short interest is 5.12 million, so 5.83% of the outstanding shares have been sold short.
| Short Interest | 5.12M |
| Short Previous Month | 5.66M |
| Short % of Shares Out | 5.83% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.67 |
Income Statement
In the last 12 months, Amdocs had revenue of $4.58 billion and earned $571.14 million in profits. Earnings per share was $5.17.
| Revenue | 4.58B |
| Gross Profit | 1.72B |
| Operating Income | 824.57M |
| Pretax Income | 696.23M |
| Net Income | 571.14M |
| EBITDA | 1.02B |
| EBIT | 824.57M |
| Earnings Per Share (EPS) | $5.17 |
Balance Sheet
The company has $247.88 million in cash and $952.36 million in debt, giving a net cash position of -$704.49 million or -$6.55 per share.
| Cash & Cash Equivalents | 247.88M |
| Total Debt | 952.36M |
| Net Cash | -704.49M |
| Net Cash Per Share | -$6.55 |
| Equity (Book Value) | 3.47B |
| Book Value Per Share | 31.82 |
| Working Capital | 83.09M |
Cash Flow
In the last 12 months, operating cash flow was $863.72 million and capital expenditures -$108.84 million, giving a free cash flow of $754.89 million.
| Operating Cash Flow | 863.72M |
| Capital Expenditures | -108.84M |
| Depreciation & Amortization | 199.20M |
| Net Borrowing | 130.00M |
| Free Cash Flow | 754.89M |
| FCF Per Share | $7.02 |
Margins
Gross margin is 37.61%, with operating and profit margins of 18.01% and 12.47%.
| Gross Margin | 37.61% |
| Operating Margin | 18.01% |
| Pretax Margin | 15.21% |
| Profit Margin | 12.47% |
| EBITDA Margin | 22.36% |
| EBIT Margin | 18.01% |
| FCF Margin | 16.49% |
Dividends & Yields
This stock pays an annual dividend of $2.28, which amounts to a dividend yield of 3.54%.
| Dividend Per Share | $2.28 |
| Dividend Yield | 3.54% |
| Dividend Growth (YoY) | 9.47% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 41.60% |
| Buyback Yield | 4.44% |
| Shareholder Yield | 7.98% |
| Earnings Yield | 8.26% |
| FCF Yield | 10.92% |
Analyst Forecast
The average price target for Amdocs is $92.33, which is 43.66% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $92.33 |
| Price Target Difference | 43.66% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 4.10% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Amdocs has an Altman Z-Score of 4.76 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.76 |
| Piotroski F-Score | 5 |